Nikita Vashisht

ICICI Bank Q3 results preview: Check profit, NIM, loan growth expectations

ICICI Bank Q3FY26 results preview: Brokerages expect moderate profit growth, stable loan growth, margin pressure and higher provisions

HDFC Bank Q3 results preview: Profit may post muted growth; NIMs stable

HDFC Bank Q3FY26 results preview: Analysts see gradual earnings recovery with stable margins, improving loan growth and pressure on deposits. Check brokerage estimates

RIL Q3FY26 results preview: O2C, Jio seen driving earnings growth

RIL Q3FY26 results preview: Brokerages expect ~10 per cent Y-o-Y Ebitda growth led by O2C and Jio, partly offset by Retail. Check earnings estimates, segment-wise outlook and key monitorables

70% of Nifty 500 stocks in red in Jan 2026: What's next for Indian markets?

Indian stock markets start 2026 on a weak note, with 70 per cent of Nifty 500 stocks in red amid FII selling, global uncertainty, and tariff worries

Markets to stay sideway till US-India sign trade deal: Shreyash Devalkar

A breakthrough in negotiations or clarity on tariff policy could lift sentiment, said Shreyash Devalkar, Head - Equity at Axis AMC

Broader geopolitical risks not fully priced-in, says Trideep Bhattacharya

Indian equities outlook 2026: Trideep Bhattacharya of Edelweiss MF decodes geopolitical risks, Budget 2026 expectations, sector winners, consumption revival and portfolio strategy

AGR relief boosts Vodafone Idea outlook; analysts flag spectrum dues risk

Vodafone Idea shares fell 2% despite 10-year AGR moratorium. Analysts cite spectrum dues, funding risks, and limited upside despite cash-flow relief

Hitachi Energy, GE Vernova shares sink up to 11% in 2 days; time to buy?

Power equipment stocks plunged for a second day amid reports the government may ease curbs on Chinese firms bidding for contracts. Hitachi Energy, GE Vernova, CG Power fall

Nifty below 26,000: Key levels to watch and trading strategy ahead

Indian stock markets fell sharply on January 8, 2026, with Sensex down 780 points and Nifty below 26,000 amid US tariff fears. Analysts suggest support, resistance and strategy ahead for markets

Emkay sets Nifty 2026 target at 29,000; sees select SMIDs generating alpha

In the worst-scenario, though, Emkay Global warns that Nifty may hit 25,000 in Q1-2026. Rupee weakness, and US tariff uncertainy remain key risks

HDFC Bank down 4% in 2 days, falls below 200-DMA: analysts decode strategy

HDFC Bank shares slide 4% in two days and fall below the 200-DMA. Analysts explain FII selling, Q3FY26 update impact and strategy ahead.

Venezuela's IBC Index zooms 16%, hits 52-week high following US attack

Venezuela's IBC Index jumps 16% to a 52-week high after a US attack, as investors bet on sanctions relief, oil revival and political change

Emkay Global upgrades Bajaj Auto to 'Buy' on EV momentum, export recovery

Emkay Global upgrades Bajaj Auto to 'Buy', raises target to ₹11,100 citing EV leadership, export recovery, EPS upgrades and strong risk-reward outlook

US attack on Venezuela: Impact on oil, Indian stock markets, energy stocks

Analyze how the US capture of President Maduro impacts India's energy security, RIL, ONGC, and the stock market. Get expert views from PL Capital & Choice Equity

Analysts bullish on Devyani after Sapphire Foods merger approval

Brokerages remain positive on Devyani International after the Board's approval of Sapphire Foods merger, citing scale benefits, cost synergies and stronger QSR economics

ITC stock downgraded as excise duty hike raises margin, volume growth risks

ITC earnings estimates for FY27-28 have been cut after a sharp excise duty hike on cigarettes. Brokerages have downgrade the stock, citing margin and volume risks

India vs global markets: Will 2026 reverse AI-led underperformance?

Will Indian markets outperform global markets in 2026? Analysts weigh earnings recovery, valuations, AI risks to forecast Indian equities outlook for the new year

Ajanta Pharma shares up 3% as Biocon tie-up fuels long-term growth optimism

Ajanta Pharma shares gained 3% despite a weak market as analysts turned bullish on its Biocon partnership, semaglutide opportunity, and growth outlook

Gold, Silver outlook for 2026: Precious metals brace for consolidation

After a record rally in 2025, will gold and silver sustain gains in 2026? Analysts flag consolidation, price targets, risks and investor strategy

Lenskart: Emkay Global sees 6x revenue growth potential, initiates 'Buy'

Lenskart stock gets 'Buy' rating from Emkay Global with ₹525 target as brokerage highlights market leadership, tech edge and strong growth outloo